luxafimloc   Click here for help

GtoPdb Ligand ID: 14692

Synonyms: GSK3882347
Compound class: Synthetic organic
Comment: Luxafimloc (also known as GSK3882347) is an orally bioavailable, mannose-containing small molecule with promising anti-virulence activity against uropathogenic Gram-negative bacteria. The chemical structure is claimed in GSK patent WO2020012336A1 [1] and was presented during the ACS Fall 2026 meeting's First Time Disclosures session [2].
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 5
Rotatable bonds 4
Topological polar surface area 110.38
Molecular weight 396.38
XLogP 0.56
No. Lipinski's rules broken 0

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC1=CC(=CC=C1[C@H]([C@@H]2[C@H]([C@H]([C@@H]([C@@H](CO)O2)O)O)O)O)C3=CC(=CC(=C3)F)F
Isomeric SMILES FC=1C=C(C=C(C1)F)C2=CC(=C(C=C2)[C@H]([C@@H]3[C@H]([C@H]([C@@H]([C@@H](CO)O3)O)O)O)O)C
InChI InChI=1S/C20H22F2O6/c1-9-4-10(11-5-12(21)7-13(22)6-11)2-3-14(9)16(24)20-19(27)18(26)17(25)15(8-23)28-20/h2-7,15-20,23-27H,8H2,1H3/t15-,16-,17-,18+,19+,20-/m1/s1
InChI Key MDGCFZRSOKMPFJ-QONVVCGCSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

References
1. Bishop MJ, Colandrea VJ, Li Y, Stewart EL, Strambeanu I, Widdowson KL, Janetka JW, McGrane LK. (2020)
C-mannoside compounds useful for the treatment of urinary tract infections.
Patent number: WO2020012336A1. Assignee: GlaxoSmithKline Intellectual Property Development Ltd, Fimbrion Therapeutics Inc. Priority date: 08/07/2019. Publication date: 16/01/2020.
2. McGrane L, Martin S, Hibbing M, Stewart E, Eddershaw P, Meinhold D, Shewchuk L, Wang L, Strambeanu I, Colandrea V et al.. 
4536652 - Discovery of GSK3882347, an orally bioavailable, FimH antagonist for uncomplicated urinary tract infections.
Accessed on 16/09/2026. Modified on 16/09/2026. MEDI First Time Disclosures: - ACS Fall 2026 - American Chemical Society, https://acs.digitellinc.com/live/37/session/594481